Caveolae: From basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo

Advanced Drug Delivery Reviews

Volumn 49, Issue 3, 2001, Pages 265-280

  Schnitzer, Jan E ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

Caveolae; Drug delivery; Dynamin; Endocytosis; Endosome; Gene therapy; Trafficking; Transcytosis; VAMP

Indexed keywords

DISEASES; DRUG THERAPY; GENES; PROBES; TISSUE;

TRAFFICKING;

PHARMACODYNAMICS;

ADENOSINE TRIPHOSPHATASE; ALBUMIN; AQUAPORIN 1; CALCIUM ION; CHOLESTEROL; CLATHRIN; DYNAMIN; GLYCOLIPID; GUANOSINE TRIPHOSPHATASE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL TRISPHOSPHATE; LIPOCORTIN 2; LIPOCORTIN 4; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITIDE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN KINASE C; SNARE PROTEIN; SPHINGOMYELIN; SYNAPTOBREVIN;

CAVEOLA; CELL MEMBRANE TRANSPORT; CONJUGATE; DRUG DELIVERY SYSTEM; DRUG SPECIFICITY; ENDOCYTOSIS; ENDOSOME; GENE TARGETING; GENE THERAPY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MEMBRANE FUSION; MEMBRANE STRUCTURE; MEMBRANE VESICLE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCYTOSIS;

ANIMALS; CAVEOLAE; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENETIC VECTORS; HUMANS;

EID: 0035963903     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00141-7     Document Type: Review

References (107)

1. Fine structure of blood capillaries
2. The fine structure of the gall bladder epithelium of the mouse
3. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association
4. Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae
5. Role of caveolae in mechanotransduction
6. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains
7. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae
8. Caveolae from luminal plasmalemma of rat lung endothelium: Microdomains enriched in caveolin, Ca(2+)-ATPase, and inositol trisphosphate receptor
9. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation
10. Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae
11. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
12. Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae
13. Caveolar internalization of growth hormone
14. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane
15. Albondin-mediated transcytosis of albumin. Purification of endothelial caveolae reveals the molecular machinery for fusion-dependent, albondin-mediated transcytosis of albumin
16. Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules
17. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases
18. NEM inhibits transcytosis, endocytosis, and capillary permeability: Implication of caveolae fusion in endothelia
19. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes
20. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium
21. Potocytosis: Sequestration and transport of small molecules by caveolae
22. Dynamin-mediated internalization of caveolae
23. Caveolae require intact VAMP for targeted transport in vascular endothelium
24. Regulated internalization of caveolae
25. Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway
26. Endothelial plasmalemmal vesicles have a characteristic striped bipolar surface structure
27. Caveolin, a protein component of caveolae membrane coats
28. Oligomeric structure of caveolin: Implications for caveolae membrane organization
29. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles
30. VIP21-caveolin, a protein of the trans-Golgi network and caveolae
31. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro
32. Endocytosis of simian virus 40 into the endoplasmic reticulum
33. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae
34. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae
35. Caveolar endocytosis of Simian virus 40 reveals a novel two-step vesicular transport pathway to the ER
36. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins
37. High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors
38. Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins
39. Transcytosis of albumin in capillary endothelium
40. Transendothelial transport of serum albumin: A quantitative immunocytochemical study
41. How protein hormones reach their target cells. Receptor-mediated transcytosis of hCG through endothelial cells
42. The role of vesicles in the transport of ferritin through frog endothelium
43. The transport of albumin: A critique of the vesicular system in transendothelial transport
44. Interaction of serum proteins with lung endothelial glycocalyx: Its effect on endothelial permeability
45. Immunoelectron microscopic localization of albumin in smooth and striated muscle tissues of rat
46. Binding and uptake of native and glycosylated albumin-gold complexes in perfused rat lungs
47. Transcytosis of alpha1-acidic glycoprotein in the continuous microvascular endothelium
48. Specific albumin binding to microvascular endothelium in culture
49. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis
50. Endothelial plasmalemmal vesicles as elements in a system of branching invaginations from the cell surface
51. The three-dimensional organization of plasmalemmal vesicular profiles in the endothelium of rat heart capillaries
52. The three-dimensional organization of smooth endoplasmic reticulum in capillary endothelia: Its possible role in regulation of free cytosolic calcium
53. The endothelial vesicle system in cryofixed frog mesenteric capillaries analysed by ultrathin serial sectioning
54. Three-dimensional organization of the plasmalemmal vesicular system in directly frozen capillaries of the rete mirabile in the swim bladder of the eel
55. Three-dimensional organization of plasmalemmal vesicles in endothelial cells. An analysis by serial sectioning of frog mesenteric capillaries
56. Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations
57. Caveolae: Static inpocketings of the plasma membrane, dynamic vesicles or plain artifact?
58. Capillary transport of macromolecules: Pores and other endothelial pathways
59. Transport functions of the glycocalyx, specific proteins and caveolae in endothelium
60. Endothelial transport of macromolecules: Transcytosis and endocytosis. A look from cell biology
61. Isolation and partial characterization of the luminal plasmalemma of microvascular endothelium from rat lungs
62. Separation of caveolae from associated microdomains of GPI-anchored proteins
63. Albumin interacts specifically with a 60-kDa microvascular endothelial glycoprotein
64. Immunoisolation of caveolae with high affinity antibody binding to the oligomeric caveolin cage. Toward understanding the basis of purification
65. Isolation and subfractionation of plasma membranes to purify caveolae separately from glycosyl-phosphatidylinositol-anchored protein microdomain
66. Differential endocytosis of antibodies to caveolae-specific proteins vs. GPI-anchored proteins
67. Cell surface dynamics of GPI-anchored proteins
68. Targeting endothelial caveolae for specific transcytosis in vivo
69. Studies on blood capillaries. II. Transport of ferritin molecules across the wall of muscle capillaries
70. Permeability of muscle capillaries to small heme-peptides. Evidence for the existence of patent transendothelial channels
71. Transcapillary transport of solute by the endothelial vesicular system: Evidence from thin serial section analysis
72. Endocytosis
73. Receptor-mediated transport of insulin across endothelial cells
74. Endocytosis and exocytosis of transferrin by isolated capillary endothelium
75. Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin
76. Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium
77. Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ
78. Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism
79. Caveolin-enriched caveolae purified from endothelium in situ are transport vesicles for albondin-mediated transcytosis of albumin
80. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin
81. Caveolin transfection results in caveolae formation but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells
82. Caveolin-enriched caveolae purified from endothelium in situ are transport vesicles for albondin-mediateed transcytosis of albumin
83. Nucleotide-dependent conformational changes in dynamin: Evidence for a mechanochemical molecular spring
84. Transport vesicle docking: SNAREs and associates
85. SNAREs and NSF in targeted membrane fusion
86. Synaptobrevin: An integral membrane protein of 18,000 daltons present in small synaptic vesicles of rat brain
87. A synaptic vesicle membrane protein is conserved from mammals to Drosophila
88. Analysis of the structure and expression of the VAMP family of synaptic vesicle proteins
89. Vascular targeting as a strategy for cancer therapy
90. The next frontier of molecular medicine: Delivery of therapeutics
91. Targeted vectors for gene therapy
92. Theory and practice of site-specific drug delivery
93. The macroscopic and microscopic pharmacology of monoclonal antibodies
94. Drug targeting to the lungs
95. Structure of solid tumors and their vasculature: Implications for therapy with monoclonal antibodies
96. Therapeutic strategies with monoclonal antibodies and immunoconjugates
97. Update on the cellular and molecular basis of capillary permeability
98. Biodistribution of monoclonal IgG1, F(ab′)2, and Fab′ in mice after intravenous injection. Comparison between anti-B cell (anti-LyB8.2) and irrelevant (MOPC-21) antibodies
99. The pharmacology of monoclonal antibodies
100. Gene therapy approaches for inherited and acquired lung diseases
101. The endothelial cell surface and caveolae in health and disease
102. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae
103. Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae
104. Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia
105. Aquaporin-1 in plasma membrane and caveolae provides mercury-sensitive water channels across lung endothelium
106. Calcium pump of the plasma membrane is localized in caveolae